Publication & Citation Trends
Publications
237 total
P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA OA
Cited by 1
Semantic Scholar
Feasibility of cryocompression for bortezomib-induced peripheral neuropathy (BIPN) among patients with multiple myeloma (MM).
Cited by 0
Semantic Scholar
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma PDF
Cited by 443
OpenAlex
A novel, immunotherapy-based approach for the treatment of relapsed/refractory multiple myeloma (RRMM): Updated phase 1b results for daratumumab in combination with teclistamab (a BCMA x CD3 bispecific antibody).
Cited by 26
Semantic Scholar
S183: NOVEL COMBINATION IMMUNOTHERAPY FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS FOR TALQUETAMAB (A GPRC5D X CD3 BISPECIFIC ANTIBODY) IN COMBINATION WITH DARATUMUMAB OA
Cited by 13
Semantic Scholar
A Phase 1 First-in-Human Study of Abbv-383, a BCMA × CD3 Bispecific T-Cell-Redirecting Antibody, As Monotherapy in Patients with Relapsed/Refractory Multiple Myeloma OA
Cited by 16
Semantic Scholar
OAB-055: Updated results of a phase 1, first-in-human study of ABBV-383, a BCMA × CD3 bispecific T-cell redirecting antibody, in patients with relapsed/refractory multiple myeloma
Cited by 0
Semantic Scholar
S188: TECLISTAMAB IN COMBINATION WITH DARATUMUMAB, A NOVEL, IMMUNOTHERAPY-BASED APPROACH FOR THE TREATMENT OF RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED PHASE 1B RESULTS OA
Cited by 13
Semantic Scholar
Research Topics
Acute Myeloid Leukemia Research
(54)
Lymphoma Diagnosis and Treatment
(47)
Hematopoietic Stem Cell Transplantation
(47)
Multiple Myeloma Research and Treatments
(42)
Acute Lymphoblastic Leukemia research
(35)
Affiliations
Dartmouth College
Northwestern University
Tufts University
University of Maryland, Baltimore
Atrium Health Wake Forest Baptist